MUC5AC and pancreatic neoplasm: This discrepancy in outcomes following adjuvant chemotherapy has also been observed in other mucin-containing pancreatic tumors, like invasive IPMN, showing no survival benefit of adjuvant chemotherapy in early tumor stages [23–26].